Quick Answer
Lucid Diagnostics Inc. reported Research And Development Expense of $5.68 million for the year ending 2025.
- Lucid Diagnostics Inc. showed a decrease of -5.2% in Research And Development Expense from 2024 to 2025.
- This data is from Lucid Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Lucid Diagnostics Inc.'s Research And Development Expense has grown by 4.3%.
- Historical annual values: Fiscal year 2025: $5.68 million | Fiscal year 2024: $5.99 million | Fiscal year 2023: $7.25 million | Fiscal year 2022: $11.26 million | Fiscal year 2021: $9.30 million | Fiscal year 2020: $5.44 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: